Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Hypercholesterolemia · Hyperlipidemia · ESPR

Esperion Therapeutics

Esperion Therapeutics patent portfolio — 55 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
Ann Arbor, US HQ
5 Employees
Public company Type
ESPR · NYSE Ticker
Company details
Status
Public
HQ
Ann Arbor, US
Employees
5
Programs
15
Drugs
9
Patents
55
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Patents

Esperion Therapeutics patents

55 pharmaceutical patents indexed for Esperion Therapeutics. 4 expire within 24 months.

Esperion Therapeutics has 55 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 4 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

55 patents

Patent portfolio

Page 1 of 2

  1. US 12404227

    Methods of making bempedoic acid and compositions of the same

    Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12398087

    Methods of making bempedoic acid and compositions of the same

    Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12344578

    Salt forms of bempedoic acid and methods for using the same

    Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11987548

    Methods of making bempedoic acid and compositions of the same

    Expires Mon May 16 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11926584

    Methods of making bempedoic acid and compositions of the same

    Expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11760714

    Methods of making bempedoic acid and compositions of the same

    Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11744816

    Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease

    Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11613511

    Methods of making bempedoic acid and compositions of the same

    Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11407705

    Methods of making bempedoic acid and compositions of the same

    Expires Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10941095

    Hydroxyl compounds and compositions for cholesterol management and related uses

    Expires Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10912751

    Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease

    Expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10118881

    Hydroxyl compounds and compositions for cholesterol management and related uses

    Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10047028

    Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

    Expires Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9624152

    Hydroxyl compounds and compositions for cholesterol management and related uses

    Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9610324

    Apolipoprotein mixtures

    Expires Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9452964

    Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

    Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9006290

    Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

    Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9000041

    Hydroxyl compounds and compositions for cholesterol management and related uses

    Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8975300

    Ketone compounds and compositions for cholesterol management and related uses

    Expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8642653

    Ketone compounds and compositions for cholesterol management and related uses

    Expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8623915

    Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

    Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8497301

    Hydroxyl compounds and compositions for cholesterol management and related uses

    Expires Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8309604

    Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

    Expires Mon Nov 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8153690

    Cycloalkyl-hydroxyl compounds and compositions for cholesterol management

    Expires Mon Apr 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8119590

    Prevention and treatment of restenosis by local administration of drug

    Expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8084498

    Ketone compounds and compositions for cholesterol management and related uses

    Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8067466

    Cycloalkyl-hydroxyl compounds and compositions for cholesterol management

    Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7838554

    Dihydroxyl compounds and compositions for cholesterol management and related uses

    Expires Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7812199

    Hydroxyl compounds and compositions for cholesterol management and related uses

    Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7709515

    Compositions comprising ether compounds and pharmaceutical uses therefor

    Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7705177

    Ketone compounds and compositions for cholesterol management and related uses

    Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7576130

    Dihydroxyl compounds and compositions for cholesterol management and related uses

    Expires Mon Aug 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7335689

    Dihydroxyl compounds and compositions for cholesterol management and related uses

    Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7335799

    Hydroxyl compounds and compositions for cholesterol management and related uses

    Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7192940

    Ether compounds

    Expires Mon Mar 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7119221

    Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

    Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 6953840

    Methods of using non-human animal Apolipoprotein A-I protein

    Expires Mon Oct 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  38. US 6909014

    Intermediates for the synthesis of ether compounds

    Expires Mon Jun 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  39. US 6831105

    Compositions comprising ether compounds and pharmaceutical uses therefor

    Expires Mon Dec 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  40. US 6790953

    Ether compounds

    Expires Mon Sep 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  41. US 6773719

    Liposomal compositions, and methods of using liposomal compositions to treat dislipidemias

    Expires Mon Aug 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  42. US 6713507

    Ether compounds and compositions for cholesterol management and related uses

    Expires Mon Mar 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  43. US 6703422

    Sulfide and disulfide compounds and compositions for cholesterol management and related uses

    Expires Mon Mar 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  44. US 6699910

    Ketone compounds and compositions for cholesterol management and related uses

    Expires Mon Feb 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  45. US 6673780

    Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses

    Expires Mon Jan 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  46. US 6646170

    Intermediates for the synthesis of ether compounds

    Expires Mon Nov 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  47. US 6617134

    Dimer of molecular variant of apolipoprotein and processes for the production thereof

    Expires Mon Sep 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  48. US 6506799

    Methods of treating cardiovascular diseases, dyslipidemia, dyslipoproteinemia, and hypertension with ether compounds

    Expires Mon Jan 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Esperion Therapeutics have?

55 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Esperion Therapeutics patents expire?

4 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.